News archive for Brenk lab
Read about druggabily predictions for RNA targets, the current state of fragment-based drug discovery for RNA, and an experimental toolbox to push drug discovery for antibiotics.
Vipul has presented an update of our JPIAMR EXPLOR project on a recent JPIAMR workshop (25:55 to 38:02)
An Experimental Toolbox for Structure-Based Hit Discovery for P. Aeruginosa FabF, a Promising Target for Antibiotics
Researchers at the Department of Biomedicine focus on large RNA structures in bacteria as a target for new antibiotics. Read the latest review article on riboswitches.
Congratulations to Illimar who got the price for the second best oral presentation at the 34. Molecular Modeling Workshop 2020 in Erlangen. Well done!
We have received funding from the Olav Tjomslands Legat for funding for equipment and tools for the the crystallization lab.
Another paper from the Brenk group published.
Ludvik has joined the lab as PhD student in November. Welcome and good luck with your project!
The Nor-Openscreen application for this year's infrastructure call scored the highest possible marks in all categories! To quote from the reviewer comments: "This is an excellent proposal to enlarge and update existing infrastructure and services in chemical biology in Norway". Despite the very favorable evaluation, the proposal was not funded. This means, there will unfortunately... Read more
Our new paper on entangling selectivity determining features and on how to use this knowledge to design selective ligands has been published in J Med Chem!
Towards better computational approaches and responsible innovation strategies in early drug discovery (18.12.2018)
Together with Nathalie Reuter and Bengt-Erik Haug from the Chemistry Department and Alexander Lundervold from the Høgskulen på Vestlandet (HVL) we got funding for the project «Towards better computational approaches and responsible innovation strategies in early drug discovery: application to antibiotics and COPD» under the Centre for Digital Life umbrella. In this project, we are aiming toward... Read more
Our EXPLORE network application aiming at targeting the TPP riboswitch for hit discovery for new antibiotics will receive funding from JPI-AMR! Other partners in the network are Daniel Lafontaine (Université de Sherbrooke, Canada), Matthias Mack (Mannheim University of Applied Sciences, Germany), Petr Bartunek (CZ-OPENSCREEN, Czech Republic), Bengt Erik Haug (University of Bergen Norway) and... Read more
Researcher's Grand Prix-cadidate Illimar Hugo Rekand is working to keep us healthy. He is investigating new opportunities for making new medicines in a world where antibiotic resistance is an increasing challenge.
A recording of Ruth's presentation of riboswitch ligand design at the Digital Life 2018 conference.
Ruth Brenk at The Department of biomedicine received a grant of 7 million NOK for research to discover new antibiotics. The work will be carried out with collaborators at the Indian Institute of Chemical Technology.
Our research about development of riboswitch ligands was chosen as partner project for Digital Life Norway.
About state-of the art of riboswitch ligand design and future perspectives.
- August 2021 (1)
- June 2021 (1)
- May 2021 (1)
- January 2021 (1)
- March 2020 (2)
- February 2020 (2)
- December 2019 (1)
- September 2019 (1)
- August 2019 (1)
- December 2018 (1)
- October 2018 (1)
- September 2018 (1)
- April 2018 (1)
- December 2017 (1)
- November 2017 (1)
- October 2017 (1)
- December 2016 (2)
- September 2016 (1)
- May 2016 (2)